Mesenchymal Stem Cell-Derived Extracellular Vesicles Protect Human Corneal Endothelial Cells from Endoplasmic Reticulum Stress-Mediated Apoptosis
Overview
Chemistry
Molecular Biology
Authors
Affiliations
Corneal endothelial dystrophy is a relevant cause of vision loss and corneal transplantation worldwide. In the present study, we analyzed the effect of mesenchymal stem cell (MSC)-derived extracellular vesicles (MSC-EVs) in an in vitro model of corneal dystrophy, characterized by endoplasmic reticulum stress. The effects of MSC-EVs were compared with those of serum-derived EVs, reported to display a pro-angiogenic activity. MSC-EVs were able to induce a significant down-regulation of the large majority of endoplasmic reticulum stress-related genes in human corneal endothelial cells after exposure to serum deprivation and tunicamycin. In parallel, they upregulated the Akt pathway and limited caspase-3 activation and apoptosis. At variance, the effect of the serum EVs was mainly limited to Akt phosphorylation, with minimal or absent effects on endoplasmic reticulum stress modulation and apoptosis prevention. The effects of MSC-EVs were correlated to the transfer of numerous endoplasmic reticulum (ER)-stress targeting miRNAs to corneal endothelial cells. These data suggest a potential therapeutic effect of MSC-EVs for corneal endothelial endoplasmic reticulum stress, a major player in corneal endothelial dystrophy.
Biomedical Application of MSCs in Corneal Regeneration and Repair.
De Miguel M, Cadenas-Martin M, Stokking M, Martin-Gonzalez A Int J Mol Sci. 2025; 26(2).
PMID: 39859409 PMC: 11766311. DOI: 10.3390/ijms26020695.
Advanced bioengineering strategies broaden the therapeutic landscape for corneal failure.
Al Monla R, Daien V, Michon F Front Bioeng Biotechnol. 2024; 12:1480772.
PMID: 39605752 PMC: 11598527. DOI: 10.3389/fbioe.2024.1480772.
Corneal Treatment, Repair, and Regeneration: Exosomes at Rescue.
Robbins B, Montreuil K, Kundu N, Kumar P, Agrahari V Pharmaceutics. 2024; 16(11).
PMID: 39598547 PMC: 11597686. DOI: 10.3390/pharmaceutics16111424.
Tanzi A, Buono L, Grange C, Iampietro C, Brossa A, Oliveira Arcolino F J Transl Med. 2024; 22(1):762.
PMID: 39143486 PMC: 11323595. DOI: 10.1186/s12967-024-05575-z.
Tati V, Mitra S, Basu S, Shukla S FEBS Open Bio. 2024; 14(6):968-982.
PMID: 38684330 PMC: 11494918. DOI: 10.1002/2211-5463.13804.